Pellegrini-Stieda disease: a heterogeneous disorder not synonymous with ossification/calcification of the tibial collateral ligament-anatomic and imaging investigation.

Pellegrini-Stieda disease: a heterogeneous disorder not synonymous with ossification/calcification of the tibial collateral ligament-anatomic and imaging investigation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pellegrini-Stieda disease: a heterogeneous disorder not synonymous with ossification/calcification of the tibial collateral ligament-anatomic and imaging investigation. Abstract Text:

Luiz F A Mendes,Michael L Pretterklieber,Jae H Cho,Glenn M Garcia,Donald L Resnick,Christine B Chung,Luiz F A Mendes,Michael L Pretterklieber,Jae H Cho,Glenn M Garcia,Donald L Resnick,Christine B Chung,

OBJECTIVE: Ossification/calcification around the medial femoral condyle has been known as Pellegrini-Stieda (PS) disease for almost 100 years. Little attention has been given to magnetic resonance (MR) imaging characteristics. Our purpose is to demonstrate the anatomy in the medial femoral compartment and imaging findings of PS disease, determining the sites and patterns of ossification. DESIGN AND PATIENTS: In a cadaveric study seven specimens were dissected to show the anatomic relations of the tibial collateral ligament (TCL) and the tendon of the ischiocondylar part of the adductor magnus muscle, in the medial femoral epicondyle. In order to determine the nature of ossification/calcification in PS disease, MR imaging and radiographic findings in nine patients were analyzed by two observers with attention to the specific site, shape, and orientation of the ossification and its relationship to the tibial collateral ligament (TCL) and adductor magnus tendon. Available clinical history was recorded. A classification system addressing different sites and patterns of ossification was developed. RESULTS: The anatomic study showed that the TCL and the adductor magnus tendon insert at different sites in the medial femoral condyle and there is no continuation; however, some fibers of the posterior bundle of the TCL overlap the anterior aspect of the adductor magnus tendon. The imaging study showed that shape, orientation, and location of the abnormal calcification and ossification were similar on radiographic and MR imaging analysis. Ossification had an inferior orientation in six cases, a superior orientation in two cases, and both in one case. Four patterns of ossification were noted: (I) a beak-like appearance with an inferior orientation and femoral attachment was present in five cases; (II) a drop-like appearance with an inferior orientation, parallel to the femur, was evident in one case; (III) an elongated appearance with a superior orientation, parallel to the femur, was seen in two cases; and (IV) a beak-like appearance with an inferior and superior orientation, attached to the femur, was seen in one case. The ossification was present in the TCL in six cases, in the adductor magnus tendon in two cases, and in both in one case. The coronal plane was best in detecting and categorizing the ossification. CONCLUSION: Our data indicate that ossification in PS disease is not confined to the TCL but may also involve the adductor magnus tendon. In some cases, it can be related to the anatomic proximity (overlap) of the fibers of these two structures. PS disease should not be regarded as synonymous with ossification of the TCL. The ossification may be classified into four types. No clinical differences among these types appear to exist.

Pellegrini-Stieda disease: a heterogeneous disorder not synonymous with ossification/calcification of the tibial collateral ligament-anatomic and imaging investigation. Publishing Authors By Initials

LF Mendes,ML Pretterklieber,JH Cho,GM Garcia,DL Resnick,CB Chung,LF Mendes,ML Pretterklieber,JH Cho,GM Garcia,DL Resnick,CB Chung,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Pellegrini-Stieda disease: a heterogeneous disorder not synonymous with ossification/calcification of the tibial collateral ligament-anatomic and imaging investigation. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Skeletal radiology

VOLUME: 35

Page Numbers: 916-22

Journal Abbreviation: Skeletal Radiol.

ISSN: 0364-2348

DAY: 19

MONTH: 09

YEAR: 2006

Pellegrini-Stieda disease: a heterogeneous disorder not synonymous with ossification/calcification of the tibial collateral ligament-anatomic and imaging investigation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7701953

Pellegrini-Stieda disease: a heterogeneous disorder not synonymous with ossification/calcification of the tibial collateral ligament-anatomic and imaging investigation. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Pellegrini-Stieda disease: a heterogeneous disorder not synonymous with ossification/calcification of the tibial collateral ligament-anatomic and imaging investigation. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Pellegrini-Stieda disease: a heterogeneous disorder not synonymous with ossification/calcification of the tibial collateral ligament-anatomic and imaging investigation.

AFFILIATION: Department of Radiology, Veterans Administration Medical Center, 3350 La Jolla Village Drive, San Diego, CA, 92161, USA.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Skeletal Radiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pellegrini-Stieda disease: a heterogeneous disorder not synonymous with ossification/calcification of the tibial collateral ligament-anatomic and imaging investigation Related Publications

• A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
• Blockade of apoptosis as a rational therapeutic strategy for the treatment of sepsis.
• Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor.
• Distribution of respiratory mucin proteins in human nasal mucosa.
• Effect of superoxide dismutase on the development of preimplantation mouse embryos.
• Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
• Experience of Middle- and Old-Aged Women's Aging.
• Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung.
• Expression of respiratory mucins in fatal status asthmaticus and mild asthma.
• Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.
• IGF-1 protects intestinal epithelial cells from oxidative stress-induced apoptosis.
• Importance of hyperexcitability of DRG neurons in neuropathic pain.
• Improved results using extensively coated THA stems at minimum 5-year followup.
• Inhibition of transforming growth factor-beta/Smad signaling by phosphatidylinositol 3-kinase pathway.
• MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells.
• Mucus and fatal asthma.
• Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.
• Oxidative stress-induced intestinal epithelial cell apoptosis is mediated by p38 MAPK.
• Pellegrini-Stieda disease: a heterogeneous disorder not synonymous with ossification/calcification of the tibial collateral ligament-anatomic and imaging investigation.
• Postnatal depression: an update.
• Role of RacC for the regulation of WASP and phosphatidylinositol 3-kinase during chemotaxis of Dictyostelium.
• The WPA Regional Meeting "Science and Humanism" (Seoul, April 18-21, 2007).
• The clinical implementation of respiratory-gated intensity-modulated radiotherapy.
• The role of reactive oxygen species (ROS) in persistent pain.
• Using the PHQ-9 for depression screening and treatment monitoring for Chinese Americans in primary care.
• Vanadium-catalyzed addition of propargyl alcohols and imines.
• [Development of a critical thinking disposition scale for nursing students]
• [Massive gastric ulcer bleeding in a healthy full term infant]
• [Modulation of tropoelastin expression in cultured human dermal fibroblasts by heat shock.]
• [Resistance to adefovir in patients with chronic hepatitis B]